Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue KC Vitamin B12 Coverage & Billing Policy Upda…
    Ask Trek AI about this page
    CurrentBlue KCPolicy POL-PP-220

    Bariatrics and Vitamin B12 Injections

    Customize your policy alerts

    Sign up for Blue KC Policy POL-PP-220 alerts

    Get alerted when Policy POL-PP-220 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines coverage and reimbursement rules for Vitamin B12 testing and injections relating to bariatric patients and general screening, and specifies billing rules during the global surgical period. Affects professional and facility providers and multiple Blue KC lines of business.

    Policy Summary
    PayerBlue KC
    PolicyBariatrics and Vitamin B12 Injections
    Policy CodePolicy POL-PP-220
    Change TypeNo material change
    Effective DateDec 1, 2025
    Last ReviewDec 1, 2025
    Next Review DateDec 1, 202614d
    Key ActionDuring the 90-day bariatric global period, Vitamin B12 (J3420) and administration (96372) are included in the global fee and are not separately billable.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    90-dayglobal period for bariatric surgery (B12 and injection included)

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3 months
    earliest interval for repeat testing after initiation of B12 therapy
    Version 05policy version
    PROF & FACprovider/entity impacted

    Coverage Criteria and Billing Rules

    Coverage criteria and billing rules

    Covered, non‑covered, and billing rules for Vitamin B12 screening, diagnostic testing, and injections — applied as written below.

    Screening for Vitamin B12 deficiency in healthy, asymptomatic individuals is non-covered.
    Homocysteine testing for the confirmation of vitamin B12 deficiency is non-covered.
    Holotranscobalamin testing for screening, testing, or confirmation of vitamin B12 deficiency is non-covered.
    Methylmalonic acid testing is allowed to confirm vitamin B12 deficiency in asymptomatic high-risk patients with low-normal vitamin B12 or when deficiency is suspected but serum vitamin B12 is normal or low-normal.
    When a Vitamin B12 screening reveals a deficiency, any subsequent testing should be performed no sooner than 3 months after initiation of therapy for that deficiency.

    Repeat testing interval: no sooner than 3 months after therapy initiation.

    Bariatric-specific allowance

    • Screening and injections for Vitamin B12 deficiency may be allowed for patients who have undergone bariatric procedures (e.g., Roux-en-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion/duodenal switch) when performed outside of the global period.
    • During the 90-day bariatric global period, Vitamin B12 (J3420) and administration of the injection (96372) are included in the global fee and are not separately billable.

      Bariatric global period = 90 days; J3420 and 96372 bundled into global surgical package.

    B12 injections include time for pre-service evaluation; submission of an E/M (99202–99215) is allowed only if the E/M is significant, separately identifiable, and exceeds the pre-service evaluation inherent to the injection.

    Relevant Codes and Testing Intervals

    Relevant lab and injection codesmixed
    82607Cyanocobalamin (Vitamin B-12)
    82608Cyanocobalamin (Vitamin B-12); unsaturated binding capacity
    83921Organic acid, single, quantitative
    83090Homocysteine
    J3425Injection, hydroxocobalamin, IM, 10 mcg
    J3420Injection, vitamin B-12 cyanocobalamin, up to 1,000 mcg
    96372Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
    inv-03: Repeat testing after therapy initiation — No sooner than 3 months
    Repeat testing intervalWhen B12 screening reveals deficiency, any subsequent testing should be performed no sooner than 3 months after initiation of therapy.
    ContextApplies to follow-up diagnostic testing after initiation of Vitamin B12 therapy for deficiency.
    PurposeEnsures adequate time for therapeutic response before repeat measurement to avoid premature retesting.

    Billing Considerations and Prior Authorization

    Prior Authorization

    Prior Authorization / Billing Considerations

    Prior authorization is required when applicable by member benefit; verify coverage and obtain prior authorization before providing services not explicitly covered. B12 injections include time for pre-service evaluation. Submit an E/M (99202-99215) only when the E/M service is significant, separately identifiable, and clearly exceeds the pre-service evaluation inherent to the injection.

    • Affected codes: J3420 (Vitamin B12, cyanocobalamin, per 1,000 mcg) — injected product
    • Affected codes: 96372 (Therapeutic, prophylactic, or diagnostic injection) — administration
    • Affected codes: 99202-99215 (Office/outpatient E/M) — bill only if significant, separately identifiable service beyond pre-service evaluation
    • Note: Confirm whether member benefits require prior authorization for B12 laboratory testing or injections
    • Billing rule: Do not bill J3420 and 96372 separately during the 90-day global period following bariatric surgery (e.g., Roux-en-Y, gastric bypass, sleeve gastrectomy, biliopancreatic diversion/duodenal switch)

    Key Definitions

    inv-05: Bariatric — definition for bariatric treatments, commonly surgery
    Definition'Bariatric' refers to treatments, most commonly surgery, for severe obesity that help people lose weight by altering the digestive system.
    Common proceduresExamples include Roux-en-Y gastric bypass, sleeve gastrectomy, and biliopancreatic diversion/duodenal switch (see policy for context).
    RelevanceBariatric patients may have specific coverage and billing rules for Vitamin B12 screening and injections, particularly related to the surgical global period.
    inv-06: Vitamin B12 — definition and clinical role
    DefinitionVitamin B12 (cobalamin) is an essential nutrient that supports healthy nerve function, red blood cell formation, and DNA synthesis; it must be obtained from food or supplements.
    Sources
    Policy Summary
    PayerBlue KC
    PolicyBariatrics and Vitamin B12 Injections
    Policy CodePolicy POL-PP-220
    Change TypeNo material change
    Effective DateDec 1, 2025
    Last ReviewDec 1, 2025
    Next Review DateDec 1, 202614d
    Key ActionDuring the 90-day bariatric global period, Vitamin B12 (J3420) and administration (96372) are included in the global fee and are not separately billable.
    SourceLink
    On This Page
    Coverage Criteria and Billing RulesRelevant Codes and Testing IntervalsBilling Considerations and Prior AuthorizationKey Definitions
    Found naturally in animal products such as meat, eggs, and dairy; the body cannot synthesize it.
    Clinical roleUsed in screening and diagnostic evaluation of deficiency; injections and testing have specific coverage and billing considerations within the policy.